Menu

Blog

Sep 4, 2023

Two-pronged immunotherapy approach could treat most blood cancers

Posted by in categories: biotech/medical, genetics

Strategy using genetically engineered T cells would attack cancer while sparing healthy blood stem cells.

Leave a reply